Study title: Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Foscarnet | |||||
ATC code: | |||||
Document link: Chrisp P and Clissold SP 1992.pdf | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Review Article | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |